Proteomics Intl Labs Ltd has released a press release.
Funding boost for precision diagnostics Proteomics Facility
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- First patent for endometriosis blood test - granted in Japan
- PromarkerD launched into the US at major diabetes conference
- Supplementary Prospectus
- A landmark in non-invasive Esophageal Cancer diagnosis
- $12 million capital raise completed with oversubscribed SPP
Later from Proteomics International Laboratories
- AMA grants reimbursement code for Next-Gen PromarkerD test
- OxiDx test detects muscle damage in thoroughbred racehorses
- Preliminary Final Report
- PromarkerEso precisely detects early stage esophageal cancer
- Board and Management Transition
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories